Loading…
Simple
Expanded
Grid
By Venue
07: ProjMgt-StrategicPlanning [clear filter]
Thursday, June 17
 

12:00pm EDT

#504 OD: Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Component Type: Session
Level: Intermediate

Having a product approved does not guarantee uptake post approval. This session will provide recommendations to insert evidence generating diagnostic strategies earlier in clinical development and will discuss case studies on different tactics.

Learning Objectives

Identify areas of opportunity to insert diagnostic strategies to generate real-world evidence into clinical development plans; Assess existing clinical development plans for new therapeutics and integrate evidence collection to support post approval product uptake.

Chair

Earl Seltzer, MBA

Speaker

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Patrick Short

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Keith Hanigan

Right the First Time: Integrating Diagnostic Strategies into Clinical Development Plans
Jeffrey Shuster, PhD


Speakers
avatar for Earl Seltzer

Earl Seltzer

Senior Director, Global Feasibility, Labcorp Drug Development, United States
Earl Seltzer has over 17 years of industry experience shared across clinical investigator sites in the United States and working at CROs in the strategic planning and feasibility space. At Labcorp, Mr Seltzer leads the global feasibility team as part of the larger, feasibility recruitment... Read More →
KH

Keith Hanigan

US Head of Precision Medicine, Blueprint Medicines , United States
PS

Patrick Short

Chief Executive Officer, Sano Genetics, United Kingdom
JS

Jeffrey Shuster

Director, Companion Diagnostics, Covance Central Laboratory Services, United States

Thursday June 17, 2021 12:00pm - 1:00pm EDT
TBD Virtual Event Horsham, PA 19044
  06: PreClin Dev-EarlyPhaseCR, Session |   07: ProjMgt-StrategicPlanning, Session |   12: Value-Access, Session |   02: ClinTrials -ClinOps, Session |   11: Statistics, Session |   20: Early Access Content, Session

12:00pm EDT

#508 OD: Leveling Up: How Building Your Emotional Intelligence Will Make You an Effective Leader
Component Type: Session
Level: Intermediate

Across the globe, there has not been a better time to stand witness to watch our world and corporate leaders stand strong or fall short. We rely on our leaders to operate in multicultural environments, establish and build relationships, manage difficult situations, navigate fluctuating business marketplaces, possess strategic vision, and inspire trust. The most successful among them are those who possess emotional intelligence (EI). Leaders with high emotional intelligence are needed to allow organizations to remain competitive, build a followership, create new leaders, and thrive in a VUCA environment.

Learning Objectives

Discuss emotional intelligence skills and how to develop them; Discuss how and why they are critical to the success of a team; Identify tools and strategies to immediately apply your learning.

Chair

Gretchen Griffin, MS

Speaker

Utilizing Soft Skills to Navigate Hard Times
Gretchen Griffin, MS

Intuitive Leadership: A Practical Guide to Leading with Vision, Values, and Heart
Liimu McGill


Speakers
avatar for Liimu McGill

Liimu McGill

Chief Executive Officer and Partner, LSM Consulting, United States
Liimu Mcgill has more than 20 years of experience consulting to the pharmaceutical industry, and for the past 12 years has had the honor of building LSM Consulting to be one of the leading providers of training and documentation services for regulated environments within the pharmaceutical... Read More →
avatar for Gretchen Griffin

Gretchen Griffin

Vice President and Head of North America Operations, Trilogy Writing & Consulting, United States
Gretchen Griffin is a pharmaceutical professional with over 20 years of experience. The majority of her career has been spent in regulatory writing, particularly for oncology therapeutics. Her experience spans from operational (writing complex regulatory documents) to managerial (leading... Read More →

Thursday June 17, 2021 12:00pm - 1:00pm EDT
TBD Virtual Event Horsham, PA 19044
  13: ProfDevelopment, Session |   07: ProjMgt-StrategicPlanning, Session |   20: Early Access Content, Session
 
Monday, June 28
 

1:00pm EDT

#117 SL: Leveraging Pharma Intelligence Data and Statistical Modeling to Inform Project Strategies
Component Type: Session
Level: Advanced
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-528-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 21660EX90U; RN 1.00

This session will explore use of external intelligence data sources in advanced statistical modeling to inform program strategies and clinical designs. Case studies will be shared.

Learning Objectives

Describe various external data sources that can be used for statistical modeling; Identify how to use statistical modeling approaches leveraging this external data; Discuss how statistical modeling can inform and influence project strategies and clinical designs.

Chair

Mark Kryah, PMP

Speaker

Informing Drug Development via Landscape Modeling Using Pharma Intelligence Data
Zhaoling Meng, PhD, MS

Application of Advanced Modeling on Development Programs
Shameer Khader, PhD, MPH


Speakers
avatar for Mark Kryah

Mark Kryah

Senior Advisor/COO, Bio-Medicines Business Unit, Eli Lilly and Company, United States
Mark Kryah is COO/Senior Advisor in Eli Lilly’s Bio-Medicines Business Unit, leading Phase 3 development in Immunology. He has been leading global development projects for 20+ years, with extensive international and partnership experience. Mark has been involved with DIA for over... Read More →
avatar for Zhaoling Meng

Zhaoling Meng

AVP, Global Head of Clinical Modeling and Evidence Integration, Sanofi, United States
SK

Shameer Khader

Senior Director, Data Science and Artificial Intelligence, AstraZeneca, United States
Dr. Shameer Khader is currently working as a Senior Director of Data Science and Artificial Intelligence at AstraZeneca, USA. He leads a global team that focuses on leveraging trans-disciplinary (biomedical, healthcare, and clinical) big data and machine intelligence to accelerate... Read More →

Monday June 28, 2021 1:00pm - 2:00pm EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Session |   11: Statistics, Session

2:30pm EDT

#134 L: Risky Business: How to Successfully Manage Project Risk
Component Type: Workshop
Level: Intermediate
CE: ACPE 1.00 Application UAN: 0286-0000-21-541-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166ZTRTIJ; RN 1.00

Pharmaceutical drug programs by their very nature are a risky business. However, too often program risk management is overlooked. In this workshop, participants will learn how to effectively and efficiently manage risk within program teams.

Learning Objectives

Define, articulate, and analyze risks clearly; Apply the concepts learned to manage risk as a continuous process and not a one-time activity.

Chair

Matthew S Curin, PharmD

Speaker

Facilitator
Nita Ichhpurani, PMP

Facilitator
Dwayne Stanley, MBA


Speakers
avatar for Nita Ichhpurani

Nita Ichhpurani

Consultant To Daiichi Sankyo, Inc., Phase One Forward, Consultant, Canada
At Pharmacia (now Pfizer), Nita was a discovery Chemist and then PM in Clinical Pharmacology in oncology and CNS research. At MDS PS, she managed Global Central lab teams and later become the Latin American Lab Manager. At MDS PS and Celerion, she managed drug development consulting... Read More →
avatar for Dwayne Stanley

Dwayne Stanley

Director, Program Management, Kaleido Biosciences, United States
Dwayne Stanley is a Program Leadership professional who partners with cross-functional teams to design, develop and deliver products within the medical device and pharmaceutical industries. After spending almost two decades in the medical device industry, Dwayne transitioned to the... Read More →
avatar for Matthew Curin

Matthew Curin

Nemolizumab Project Management Lead, Galderma, United States
Matt has been working in the pharmaceutical industry for more than 20 years, spending the first 8 years in clinical manufacturing before moving into project management in 2007. Since then, Matt has provided project, program, and portfolio management leadership in clinical development... Read More →

Monday June 28, 2021 2:30pm - 3:30pm EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Workshop

4:00pm EDT

#144 SL: Launching Megatrials During a Pandemic: Lessons Learned from COVID-19 Vaccine Clinical Trials
Component Type: Forum
Level: Advanced
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-548-L04-P; CME 1.00; IACET 1.00; RN 1.00

As drug development moves toward precision and targeted medicines, megatrials which include tens of thousands of participants are uncommon. But the developers of COVID-19 vaccines launched complex trials of this size in 2020, encountering not just the challenges of massive clinical trials but also those of running clinical trials during the pandemic. In this forum, senior-level executives from biopharma companies which conducted COVID-19 vaccine trials will discuss the experience of clinical operations in this context, sharing what they expected and did not expect, lessons learned, and what they will take forward to the conduct of future research.

Learning Objectives

Describe some of the unique challenges of launching extremely large clinical trials; Discuss unique and innovative practices and solutions that clinical teams developed to manage these challenges; Assess ideas for best practices that can be applied to future clinical trial conduct.

Chair

Lindsay McNair, MD, MPH, MS

Speaker

Panelist
Melanie Ivarsson, PhD, MBA

Panelist
Dawn M Furey

Panelist
Sarah Tweedy


Speakers
avatar for Lindsay McNair

Lindsay McNair

Principal Consultant, Equipoise Consulting, United States
Lindsay McNair, MD, MPH, MSB is Principal Consultant at Equipoise Consulting. She was previously the Chief Medical Officer for WCG. In role she oversaw WCG IRB, and provided consultation to institutions and biopharma companies on a wide range of issues related to clinical protocol... Read More →
DF

Dawn Furey

Vice President, Portfolio Delivery Operations, Janssen, United States
Dawn Furey is a 20+ year clinical operations leader and currently VP and Head of Portfolio Delivery Operations (PDO) at Janssen, Research & Development where she leads central planning and delivery for Janssen’s active therapeutic areas (Oncology, Immunology, Neuroscience, Vaccines... Read More →
MI

Melanie Ivarsson

Chief Development Officer, Moderna, United States
avatar for Sarah Tweedy

Sarah Tweedy

Vice President, Clinical Operations Head – Vaccines, Pfizer Inc, United States

Monday June 28, 2021 4:00pm - 5:00pm EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Forum |   02: ClinTrials -ClinOps, Forum
 
Tuesday, June 29
 

10:00am EDT

#217 SL: Project Management in Times of Crisis: Perspectives from PMs Supporting COVID-19 Related Projects
Component Type: Session
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-566-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166V1QD7Y; RN 1.00

Bringing together project managers from multiple sectors who have been managing projects at the forefront of the COVID-19 global pandemic, lessons learned and critical skills for operating in this high visibility, high impact space will be shared.

Learning Objectives

Recognize and discuss the unique challenges of managing projects during times of crisis when situations are constantly evolving; Identify the critical PM skills that are most effective during times of crisis; Recognize different approaches and critical skills needed when managing through a crisis.

Chair

Erin Mulrooney, MSc

Speaker

Lessons Learned from Preparing and Submitting an IND Application for a COVID-19 Treatment Candidate
Efi Sergi, MS, PMP

Project Management in Times of Crisis: Managing a Multi-Organization Team to Deliver a COVID-19 Data Sharing Module in 7 Months
Kelsey Jakee

Update from Industry
Mark Boaz, PhD, MS


Speakers
avatar for Erin Mulrooney

Erin Mulrooney

Director, Discovery Project and Portfolio Management, Merck Sharp & Dohme LLC , United States
Erin Mulrooney is a Director in the Global Project and Alliance Management group at Merck where she manages the Discovery & Early Development Portfolio and Governance processes. Prior to rejoining Merck at the end of 2020, Erin was the Director of Portfolio Management and Operations... Read More →
avatar for Efi Sergi

Efi Sergi

Associate Director, Regulatory Project & Submission Management, PRA Health Sciences, United States
Efi Sergi is an Associate Director within PRA’s Regulatory Project and Submission Management group. She has been in the pharmaceutical industry since 2008 and has held various regulatory roles in the US and the UK. Efi has international regulatory submission management and strategic... Read More →
MB

Mark Boaz

Senior Director, Pfizer Vaccines Research and Development, Pfizer Inc, United States
Program Director for Vaccine Research & Development Program Teams. Experienced immunologist and vaccinologist. I direct COVID-19 RNA and RNA influenza programs. In addition I lead a team of 6 Program Managers. I develop forward thinking programs that maximise medical and commercial... Read More →
avatar for Kelsey Jakee

Kelsey Jakee

Principal Consultant, PA Consulting Group, United States
Kelsey Jakee is a strategy, business design and program management expert with PA Consulting, specializing in the life sciences industry. She has a demonstrated track record of delivering broad, complex and transformative initiatives to modernize R&D. She has published articles on... Read More →

Tuesday June 29, 2021 10:00am - 11:00am EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Session

2:00pm EDT

#244 SL: How to Stay Grounded in Project Management Best Practices While Moving at the Speed of Light Integrating a New Company
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-669-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 216673TIJV; RN 1.00

Mergers, acquisitions, and integrations are a necessity in the Pharmaceutical industry today. We must balance our internal capabilities with external knowledge and novel ideas to grow our pipelines of therapies for patients. In this session, we will summarize some of the key success factors for planning for a successful Day 1 Integration while balancing hefty synergy targets for a company.

Learning Objectives

Describe how to cross-functionally plan and execute for a successful large, complex integration while demonstrating empathy and understanding; Differentiate how you can keep a team engaged and motivated during a high intensity, fast moving project; Identify watch-outs/pitfalls and best practices in integrations while managing synergy targets.

Chair

Caroline Grimes

Speaker

Leading Organizations Through Successful Mergers and Acquisitions
Kyle Obergfell, PhD


Speakers
avatar for Caroline Grimes

Caroline Grimes

Senior Director, Head of Allergan R&D Migration, Portfolio & Program Management, AbbVie, Inc., United States
Carrie brings 20 years’ experience firmly rooted in project/program management and delivery of exceptional business services. She started her career working for Cap Gemini Ernst & Young. Carrie then transitioned to strengthening her project management skills starting a 300-acre... Read More →
KO

Kyle Obergfell

Principal, BCG, United States
Kyle is a Principal in the Health Care practice area at Boston Consulting Group. At BCG, Kyle has helped develop growth strategies and lead large-scale, transformational efforts across Biopharma and Provider systems. Prior to joining BCG, Kyle obtained his PhD in Microbiology and... Read More →

Tuesday June 29, 2021 2:00pm - 3:00pm EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Session

4:00pm EDT

#260 SL: What Do We Do Now? Why You Need A Resource for Ethical Questions During Drug Development
Component Type: Session
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-591-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166KDCGEN; RN 1.00

Complex ethical questions are inherent in drug development. Teams need resources to provide independent, thoughtful and informed assistance with these questions. We will look at models of ethical consultation that match organizational needs.

Learning Objectives

Recognize situations in which ethical consultation may be appropriate, useful and necessary; Identify potential resources to provide ethical consultation appropriate to the needs of the development program; Describe how to obtain ethical consultation in advance of situations in which it may be necessary.

Chair

Karla Childers, MS

Speaker

Models for Bioethical Consultation to Drug Development Teams
Lindsay McNair, MD, MPH, MS


Speakers
avatar for Karla Childers

Karla Childers

Head, Bioethics-Based Science and Technology Policy, Johnson & Johnson, United States
Karla Childers is Head, Bioethics-based Science & Technology Policy in the Johnson & Johnson Office of the Chief Medical Officer. Her primary responsibility is leading and coordinating various bioethics-based, science policy projects since 2013. Her longest running responsibility... Read More →
avatar for Lindsay McNair

Lindsay McNair

Principal Consultant, Equipoise Consulting, United States
Lindsay McNair, MD, MPH, MSB is Principal Consultant at Equipoise Consulting. She was previously the Chief Medical Officer for WCG. In role she oversaw WCG IRB, and provided consultation to institutions and biopharma companies on a wide range of issues related to clinical protocol... Read More →

Tuesday June 29, 2021 4:00pm - 5:00pm EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Session
 
Wednesday, June 30
 

10:00am EDT

#317 SL: Best Practices for Project Managers Working in Drug Development Collaborations
Component Type: Session
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-607-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166II3IH9; RN 1.00

This session will discuss how project managers can prepare themselves to work and contribute to a productive collaboration environment.

Learning Objectives

Describe how Project Managers can effectively navigate the complexity of working in a drug development collaboration; Discuss ways that Project Managers can contribute to the success of a joint team when working in a collaboration environment.

Chair

Claire Blanchette, PMP

Speaker

Best Practice: How Project Managers Can Effectively Navigate Collaborations
Claire Blanchette, PMP

Critical Skills to Manage Complexity in Collaborations
Andrea Jux

Lessons Learned: Working with Difficult Stakeholders in Partner Organizations
Delaine Ceholski, PhD, PMP


Speakers
avatar for Delaine Ceholski

Delaine Ceholski

Senior Specialist, Global Project and Alliance Management, Merck & Co., Inc., United States
Delaine Ceholski is a Senior Specialist in Global Project and Alliance Management at Merck & Co., Inc. In this role, she leads early- and late-stage drug development teams in oncology and general medicine, and sits on several collaboration teams where she works with multiple academic... Read More →
avatar for Claire Blanchette

Claire Blanchette

Executive Drug Development Program Leader, Consultant, United States
Claire Blanchette is a Vice President, Compound Development Team Leader at Genmab where she is responsible for the leadership of an oncology asset team. Claire is passionate about bringing speed and efficiency to the the drug development process so effective treatments can reach patients... Read More →
avatar for Andrea Jux

Andrea Jux

Deputy Director, Alliance Management, Bayer, United States
Andrea Jux is a Deputy Director, Alliance Management Oncology at Bayer US LLC since 2018. Andrea has 20 plus years' experience in the pharmaceutical industry. Andrea's current responsibility include Global Oncology Alliances as well as multiple early and late stage Clinical Collaborations... Read More →

Wednesday June 30, 2021 10:00am - 11:00am EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Session

2:00pm EDT

#339 SL: Best Practices in Governance Meetings
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-619-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166Z86NT1; RN 1.00

This session will discuss best practices and key success factors for enabling and maximizing the effectiveness of interactions with Governance boards. Governance structures and key elements will be examined and compared from multiple viewpoints including CRO, pharma, and biotech.

Learning Objectives

Describe the governance structures and team interactions which occur in different sectors of the industry; Discuss key elements and best practices which maximize the effectiveness of the interactions and result in high-performance outcomes including trust and transparency, identification of key performance indicators, clear definition and communication of priorities, alignment between the strategy and execution, and unambiguous decision making.

Chair

Nathan Kreischer, MS, PMP

Speaker

Best Practices in Governance: Big Pharma
Nathan Kreischer, MS, PMP

Best Practices in Governance: Contract Research Organization (CRO)
Melissa Mauriber

Best Practices in Governance: Small Biotech
Leann Frankel, MPH


Speakers
avatar for Nathan Kreischer

Nathan Kreischer

Director, Global Project & Alliance Management, Merck & Co. Inc., United States
Nathan is a Director within Global Project & Alliance Management at Merck. He has over 14 years of experience in the Pharmaceutical industry spanning Basic Research, Sales, Clinical Research and Project/Program Management. He has successfully lead teams through strategy development... Read More →
avatar for Melissa Mauriber

Melissa Mauriber

VP, Clinical Operations Quality & Talent Development, Advanced Clinical, United States
Melissa is an executive-level clinical research professional with over 25 years of industry experience with a focus on clinical operations and quality. Melissa joined Advanced Clinical as VP, Clinical Operations Quality and Talent Development, in 2015, and has applied her tenure and... Read More →
LF

Leann Frankel

Strategic Sourcing Lead - Clinical Operations, Gates Medical Research Institute, United States
Leann Frankel has 20 years of experience in the life sciences industry, focusing on Contracts and Outsourcing. She is currently an Associate Director of Vendor Relationship Management at bluebird bio, Inc. This new role within bluebird bio involves developing governance structures... Read More →

Wednesday June 30, 2021 2:00pm - 3:00pm EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Session

4:00pm EDT

#356 SL: How to Streamline Project Management Methodology Across an Organization: End Reliance on Trackers and Emails
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-631-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 21661VV0R6; RN 1.00

Project managers struggle with changing processes, technology learning curves, and information overload. By developing a platform that answers the question of “what do I do next”, preoject managers can become more proactive. We will discuss the design of the platforms, the challenges faced, the change management required for implementation, and the results.

Learning Objectives

Describe how to achieve simplification of the project managers day to day tasks by designing a platform that reduces time spent searching for next steps; Discuss how to effectively visualize progress and compliance to processes; Describe benefits of streamlining project management across an organization.

Chair

Kristin Stallcup, MS, PMP

Speaker

Panelist
Kristin Stallcup, MS, PMP

Panelist
Mark Schindler, MA

Panelist
Claire Bonaci


Speakers
MS

Mark Schindler

Managing Director, Group Visual IO, United States
Mark Schindler is co-founder and Managing Director of GroupVisual.io, a product design consultancy in Boston. For over 15 years, he has designed digital products for clients like Simons Foundation, Optum, Walmart and GE. Mark and his firm mentor startup companies, and conduct workshops... Read More →
avatar for Kristin Stallcup

Kristin Stallcup

Sr. Director, Business Success, Xcellerate, Labcorp Drug Development, United States
Kristin Stallcup brings 15 years of industry experience in various trial management capacities. Currently she serves as senior director responsible for implementation and adoption of the Xcellerate Informatics suite into business process. Previously she served in central monitoring... Read More →
avatar for Claire Bonaci

Claire Bonaci

Senior Director, US Health and Life Sciences, Microsoft, United States
Claire works in partnership with US life science companies, pharma, and health organizations to create innovative Microsoft solutions specific to the company’s issues affecting their patients and their business. She brings with her an expertise in the clinical trial and pharmaceutical... Read More →

Wednesday June 30, 2021 4:00pm - 5:00pm EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Forum
 
Thursday, July 1
 

10:00am EDT

#411 SL: Virtual Project Management: A Way Forward!
Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-641-L04-P; CME 1.00; IACET 1.00; PDU 1.00 PMI 2166U8V7DJ; RN 1.00

This forum will cover skills project management professionals need to develop and learn - like agility and adaptability to lead multi-disciplinary teams to deliver success delivery project outcomes during disruptive times. Join the Project Management Community for a follow up round table discussion (session #432 RT L) on Thursday, July 1, 12:30PM - 1:30PM EDT.

Learning Objectives

Describe the opportunities and challenges of leading projects virtually in the pharmacovigilance and patient safety, regulatory affairs, and asset team functions; Discuss ways to keep cross-functional teams engaged, conduct remote team meetings and workshops, and how to utilize tech tools as enablers for collaboration.

Chair

Hetal Doshi, MBA

Speaker

Panelist
Linette Hickson, MS

Panelist
Robert Foreman, PMP


Speakers
avatar for Hetal Doshi

Hetal Doshi

Director, Business Operations and Strategy, AbbVie, Inc., United States
Hetal Doshi has over 15 years of experience in leading global business transformation initiatives in pharmaceutical and healthcare industry. Her experience span across leading strategic initiatives in Pharmacovigilance & Patient Safety, Regulatory, Technology and Digital Health initiatives... Read More →
avatar for Linette Hickson

Linette Hickson

Senior Director, Global Regulatory Operations, Beigene, United States
Linette Hickson has over 20 year in the pharmaceutical and biotech industry. Over the past 14 years, Linette has been leading and building Regulatory Operations teams responsible for the implementation and support of global regulatory systems and processes. Linette's experience in... Read More →
avatar for Robert Foreman

Robert Foreman

Pharmaceutical Project Management, Eli Lilly and Company, United States
Robert Foreman has over 17 years of experience in the pharmaceutical industry. His career began in Discovery Biology from which he transitioned to Asset Team Project Management. Robert is PMP certified and combines his Discovery and Project Management experience to enable and lead... Read More →

Thursday July 1, 2021 10:00am - 11:00am EDT
TBD Virtual Event Horsham, PA 19044
  07: ProjMgt-StrategicPlanning, Forum

12:30pm EDT

#432 RT L: Round Table Discussion: Round Table Discussion: Virtual Project Management - New PMBOK Framework - Overview and Implications for Pharma!
Component Type: Forum

Join DIA Project Management Community for a round table discussion tied to session #411 SL Virtual Project Management: A Way Forward! scheduled for Thursday, July 1 10 - 11AM EDT. Space is limited. When the virtual room is full, attendees attempting to access the session will receive a message noting that the session has reached maximum capacity.

Chair

Mark Kryah, PMP

Speakers
avatar for Hetal Doshi

Hetal Doshi

Director, Business Operations and Strategy, AbbVie, Inc., United States
Hetal Doshi has over 15 years of experience in leading global business transformation initiatives in pharmaceutical and healthcare industry. Her experience span across leading strategic initiatives in Pharmacovigilance & Patient Safety, Regulatory, Technology and Digital Health initiatives... Read More →
avatar for Mark Kryah

Mark Kryah

Senior Advisor/COO, Bio-Medicines Business Unit, Eli Lilly and Company, United States
Mark Kryah is COO/Senior Advisor in Eli Lilly’s Bio-Medicines Business Unit, leading Phase 3 development in Immunology. He has been leading global development projects for 20+ years, with extensive international and partnership experience. Mark has been involved with DIA for over... Read More →

Thursday July 1, 2021 12:30pm - 1:30pm EDT
TBD Virtual Event Horsham, PA 19044
  16: Community Rounds, Forum |   07: ProjMgt-StrategicPlanning, Forum
 
  • Timezone
  • Filter By Date DIA 2021 Virtual Global Annual Meeting Jun 1 -Jul 1, 2021
    • June 2021
      SunMonTueWedThuFriSat
       12345
      6789101112
      13141516171819
      20212223242526
      27282930 
      July 2021
      SunMonTueWedThuFriSat
       123
      45678910
      11121314151617
      18192021222324
      25262728293031
  • Filter By Venue Virtual Meeting
  • Filter By Type
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Data Standards
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClin Dev-EarlyPhaseCR
  • 07: ProjMgt-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Posters
  • 18: Networking Opportunities
  • 19: Short Courses
  • 20: Early Access Content
  • 21: InnovationTheaters
  • 22: Solution Circles
  • 23: Spotlight Symposia
  • 24: Lunch-and-Learn
  • Beginner
  • Featured Topics
Filter sessions
Apply filters to sessions.
Tuesday, June 1
Thursday, June 3
Tuesday, June 8
Thursday, June 10
Thursday, June 17
Friday, June 18
Saturday, June 19
Sunday, June 20
Monday, June 21
Tuesday, June 22
Wednesday, June 23
Thursday, June 24
Friday, June 25
Sunday, June 27
Monday, June 28
Tuesday, June 29
Wednesday, June 30
Thursday, July 1
TBD
Virtual Event
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Data Standards
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClin Dev-EarlyPhaseCR
  • 07: ProjMgt-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Posters
  • 18: Networking Opportunities
  • 19: Short Courses
  • 20: Early Access Content
  • 21: InnovationTheaters
  • 22: Solution Circles
  • 23: Spotlight Symposia
  • 24: Lunch-and-Learn
  • Beginner
  • Advanced
  • Beginner
  • Intermediate
  • Featured Topics
  • Artificial Intelligence
  • Collaboration
  • COVID-19 - Pandemic
  • Digital Technology
  • Diversity Equity and Inclusion
  • HTA
  • Innovative Trial Design
  • Novel Therapeutic Approaches
  • Patient Focused
  • Regulator Thinking
  • RWD-RWE
  • Special Populations
  • Student Programming
  • What's Next